Enjoy complimentary customisation on priority with our Enterprise License!
The lice treatment market share is expected to increase by USD 128.97 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.26%.
This lice treatment market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers lice treatment market segmentation by distribution channel (hospitals and clinics, online, and retail pharmacies) and geography (North America, Europe, Asia, and Rest of World (ROW)). The lice treatment market report also offers information on several market vendors, including Alliance Pharma Plc, American Vanguard Corp., Arbor Pharmaceuticals LLC, Elanco Animal Health Inc., Fleming Medical Ltd., Johnson and Johnson Inc., Logic Product Group LLC, Marico Ltd., Merck and Co. Inc., Nix Pharma Pvt Ltd., PARAPRO LLC, Perrigo Co. Plc, Prestige Consumer Healthcare Inc., SHIONOGI Co. Ltd., TecLabs Inc., Teva Pharmaceutical Industries Ltd., Thornton & Ross Ltd., and Bayer AG among others.
Download the Free Report Sample to Unlock the Lice Treatment Market Size for the Forecast Period and Other Important Statistics
The increasing prevalence of lice infestation is notably driving the lice treatment market growth, although factors such as high cost of healthcare may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the lice treatment industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Lice Treatment Market Driver
One of the key factors driving growth in the lice treatment market is the increasing prevalence of lice infestation. Infestations by head lice occur widely among children. Most infected individuals do not witness serious symptoms. However, some individuals suffer from severe reactions to louse feeding. Constant itching of the scalp is a common symptom of head lice infestation and can result in the loss of concentration at work or school and sleep. Furthermore, excessive scratching can occasionally pose the risk of lymphadenopathies and secondary skin infections. Hence, such factors will boost the demand for lice treatment solutions during the forecast period.
Key Lice Treatment Market Trend
The growing population of children is another factor supporting the lice treatment market share growth. Children are more prone to lice infestation as compared to adults, as they are less protective of their personal space and hygiene. There is a rapid rise in population across the globe; hence, the rising number of children is expected to propel market growth during the forecast period. The rising prevalence of lice infestation is also significantly high in children from nomad tribes, as compared to rural and urban areas due to lack of hygiene and awareness regarding lice infestation. Therefore, the rising number of children across the globe is expected to raise the demand for lice treatment solutions during the forecast period.
This lice treatment market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Key Lice Treatment Market Challenge
The high cost of healthcare will be a major challenge for the lice treatment market during the forecast period. Developed nations such as the US, Canada, and the UK, have high healthcare costs. European countries with the most expensive healthcare systems include Switzerland, Norway, Germany, the Netherlands, Austria, Denmark, Sweden, Ireland, France, Belgium, and Luxembourg. The high cost of healthcare in these developed countries prevents patients from opting for lice treatment options. Additionally, in developing countries such as India, China, Brazil, Argentina, and others, patients are unable to avail of lice treatment due to the lack of resources and low per capita income. The absence of proper healthcare infrastructure and low-amount government aids received in the form of medical expense reimbursement act as a challenge for the patients in these countries. This will negatively affect the growth of the global lice treatment market.
Technavio categorizes the global lice treatment market as a part of the pharmaceutical market within the overall healthcare industry. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the lice treatment market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the lice treatment market encompasses successful business strategies deployed by the key vendors. The lice treatment market is fragmented and the vendors are deploying growth strategies such as focusing on offering several products to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The lice treatment market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the lice treatment market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
32% of the market's growth will originate from North America during the forecast period. The US is the key market for lice treatment in North America. Market growth in this region will be faster than the growth of the market in regions.
The presence of an increasing population of children and a large incidence of lice infestation cases will facilitate the lice treatment market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The governments of countries such as the US, Canada, and Mexico imposed nationwide lockdowns and COVID-related restrictions to curb the spread of the COVID-19 disease. This reduced the number of patients visiting healthcare centers for the treatment of lice infestation, and the regional demand for lice treatment drugs declined. However, in 2021, the number of COVID-19 cases reduced in the region due to the large-scale vaccine administration, which propelled the resumption of elective procedures in hospitals and other healthcare facilities. Thus, the regional demand for lice treatment solutions rebounded.
To gain further insights on the market contribution of various segments Request for a FREE sample
The lice treatment market share growth by the hospitals and clinics segment will be significant during the forecast period. The increasing prevalence of head lice among people across the globe is one of the major factors driving the growth of the demand for lice treatment in hospitals and clinics. Factors such as the rising investment for improving the medical formulas for the effective elimination of these parasites are expected to boost market growth during the forecast period. In addition, ease in the availability of lice treatment products in hospitals and clinics will further accelerate market growth. However, patients in underdeveloped and developing countries refrain from consulting a doctor or going to hospitals for lice infestation. This is mainly due to the lower healthcare expenditure and the common perception among people in these regions that lice infestation is not a serious medical concern.
This report provides an accurate prediction of the contribution of all the segments to the growth of the lice treatment market size and actionable market insights on post COVID-19 impact on each segment.
Lice Treatment Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.26% |
Market growth 2022-2026 |
$ 128.97 million |
Market structure |
Fragmented |
YoY growth (%) |
5.7 |
Regional analysis |
APAC |
Performing market contribution |
North America at 32% |
Key consumer countries |
US, UK, Germany, China, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Alliance Pharma Plc, American Vanguard Corp., Arbor Pharmaceuticals LLC, Elanco Animal Health Inc., Fleming Medical Ltd., Johnson and Johnson Inc., Logic Product Group LLC, Marico Ltd., Merck and Co. Inc., Nix Pharma Pvt Ltd., PARAPRO LLC, Perrigo Co. Plc, Prestige Consumer Healthcare Inc., SHIONOGI Co. Ltd., TecLabs Inc., Teva Pharmaceutical Industries Ltd., Thornton & Ross Ltd., and Bayer AG |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Distribution Channel
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.